Full-Course Oral Levofloxacin for Treatment of Hospitalized Patients with Community-Acquired Pneumonia

By Erard V.   Lamy O.   Bochud P.-Y.   Bille J.   Cometta A.   Calandra T.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 2, 2004-02 ,pp. : 82-88

Springer Publishing Company

Access to resources Recommend Favorite

Penetration of levofloxacin into the anterior chamber (aqueous humour) of the human eye after intravenous administration

By García-Vázquez E.   Mensa J.   Sarasa M.   López Y.   Couchard P.   Soy D.   Fontenla J.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 2, 2007-02 ,pp. : 137-140

Springer Publishing Company

Access to resources Recommend Favorite

Determining the Frequency of Resistance of to Ciprofloxacin, Levofloxacin, Trovafloxacin, Grepafloxacin, and Gemifloxacin

By Evans M.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, Iss. 12, 2001-12 ,pp. : 883-885

Springer Publishing Company

Access to resources Recommend Favorite

Effect of cytokine treatment on the in vitro expression of the P. falciparum adhesion receptor chondroitin-4-sulphate on the surface of human choriocarcinoma (BeWo) cells

By Adams Yvonne   Schwartz-Albiez Reinhard   McCarthy James   Andrews Katherine  

Parasitology Research, Vol. 101, Iss. 2, 2007-07 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

Cytokine-Mediated Control of Viral Infections

By Guidotti L.G.   Chisari F.V.  

Virology, Vol. 273, Iss. 2, 2000-08 ,pp. : 221-227

Elsevier

Access to resources Recommend Favorite